United Santkrupa Superspeciality Hospital And Research Unit Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 0.49%
(FY 2022)
- Ebitda
- Net Worth -368.43%
(FY 2022)
- Total Assets
About United Santkrupa Superspeciality Hospital And Research Unit
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pandharinath Mante and Seema Mante serve as directors at the Company.
- CIN/LLPIN
U85310MH2018PTC310055
- Company No.
310055
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2018
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalna, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at United Santkrupa Superspeciality Hospital And Research Unit?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pandharinath Mante  | Director | 29-May-2018 | Current |
| Seema Mante | Director | 10-Sep-2020 | Current |
Financial Performance of United Santkrupa Superspeciality Hospital And Research Unit.
United Santkrupa Superspeciality Hospital And Research Unit Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.49% increase in profit. The company's net worth observed a substantial decline by a decrease of 368.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of United Santkrupa Superspeciality Hospital And Research Unit?
Unlock access to United Santkrupa Superspeciality Hospital And Research Unit's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at United Santkrupa Superspeciality Hospital And Research Unit?
Unlock and access historical data on people associated with United Santkrupa Superspeciality Hospital And Research Unit, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of United Santkrupa Superspeciality Hospital And Research Unit, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped United Santkrupa Superspeciality Hospital And Research Unit's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
